PRESS RELEASE published on 08/14/2024 at 23:30, 1 year 9 months ago Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property Medicure Inc. acquires intellectual property assets of CanAm Bioresearch Inc. related to new chemical entities for therapeutic use. Agreement terms and related party transaction details provided Medicure Inc. New Chemical Entities Therapeutic Use CanAm Bioresearch Inc. Intellectual Property Assets
BRIEF published on 08/14/2024 at 23:05, 1 year 9 months ago Medicure publie ses résultats financiers pour le trimestre clos le 30 juin 2024 Résultats Financiers Medicure AGGRASTAT ZYPITAMAG Drogue Marley
BRIEF published on 08/14/2024 at 23:05, 1 year 9 months ago Medicure Reports Financial Results for Quarter Ended June 30, 2024 Financial Results Marley Drug Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE published on 08/14/2024 at 23:00, 1 year 9 months ago Medicure Reports Financial Results for Quarter Ended June 30, 2024 Medicure Inc. reports Q2 2024 financial results: net revenue down, EBITDA negative, net loss recorded. AGGRASTAT and ZYPITAMAG sales impacted. Analyst call on Aug 15, 2024 Financial Results EBITDA Medicure Inc. Net Loss Q2 2024
BRIEF published on 06/24/2024 at 23:05, 1 year 10 months ago Medicure Announces Acquisition Agreement with CanAm Bioresearch Inc. Pharmaceuticals Intellectual Property Asset Purchase Medicure CanAm Bioresearch
BRIEF published on 06/24/2024 at 23:05, 1 year 10 months ago Medicure annonce un accord d'acquisition avec CanAm Bioresearch Inc. Médicament Propriété Intellectuelle Médicaments CanAm Biorecherche Achat D'actifs
PRESS RELEASE published on 06/24/2024 at 23:00, 1 year 10 months ago Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF published on 05/28/2024 at 23:05, 1 year 11 months ago Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs Résultats Financiers Médicament T1 2024 Élection Du Directeur
BRIEF published on 05/28/2024 at 23:05, 1 year 11 months ago Medicure Reports Financial Results for Q1 2024 and Director Election Results Financial Results Director Election Q1 2024 Medicure
PRESS RELEASE published on 05/28/2024 at 23:00, 1 year 11 months ago Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
Published on 05/16/2026 at 01:15, 23 hours 13 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 1 hour ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 1 hour ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 8 hours 19 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 4 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 6 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 9 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 9 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 14 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 15 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 6 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES